IgG antibody testing method
AssigneeMidland Bioproducts Corporation
InventorsJerry K. McVicker, Glenda C. Rouse, Denny M. Barrantes
Life of this patent
Estimating the term…
Loading patent…
AssigneeMidland Bioproducts Corporation
InventorsJerry K. McVicker, Glenda C. Rouse, Denny M. Barrantes
Estimating the term…
A method of determining the concentration of IgG antibodies in the biological fluids of mammals. The assay may be performed in a lateral flow cassette or dipstick format where dehydrated immobilized reagents are spaced along a membrane. A sample of a mammalian biological fluid is exposed first to an IgG complexing agent to yield a conjugate. The conjugate then moves along the membrane and is exposed to a standard mammalian IgG applied to the membrane at a test position. Binding of the IgG is indicated by a color change at the test position on the membrane. A control reagent of dehydrated anti-IgG complexing agent may be applied to the membrane at the control position spaced downstream from the test position. Interaction of the IgG complexing agent with the anti-IgG complexing agent forms a visible line at the control position on the membrane.
A method of determining if the concentration of IgG antibodies in biological fluids of a mammal is below a predetermined threshold level, the method comprising the steps of:
A method of determining if the concentration of IgG antibodies in biological fluids of a mammal is below a predetermined threshold level, the method comprising the steps of:
Dependencies are inferred from the claim text.